Clinical journal of oncology nursing
-
Intraperitoneal (IP) chemotherapy is often a preferred treatment for ovarian cancer because of its clinical benefits, but research on the experiences of patients receiving IP chemotherapy is limited. ⋯ The following themes emerged from the data.